Bharat Biotech has submitted necessary information to Indian Council of Medical Research ( ICMR ) four days ago . The company is now looking to seek Prime Minister Narendra Modi s approval to expedite regulatory clearances . When Ebola vaccine candidates were being discussed , the company had skipped phase 2 trials and went on to phase three with a small sample size . Given the urgency of the situation , something of that sort will be required , he added . Currently , getting regulatory approvals takes for conducting clinical trials in India can take up to 6 8 months .
